Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers
暂无分享,去创建一个
D Simon | B S Schwartz | K I Bolla | W F Stewart | A C Todd | J. Links | W. Stewart | B. Schwartz | A. Todd | D. Simon | K. Bolla | J Links | Walter F. Stewart | B. Schwartz
[1] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[2] J. Mazziotta,et al. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. , 1994, The New England journal of medicine.
[3] P M Matthews,et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.
[4] Y. Karouji,et al. Clinico-epidemiologic study of stroke in Akita, Japan. , 1987, Stroke.
[5] P. Sandercock,et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[6] K. Welch,et al. Migraine-related stroke in the context of the International Headache Society classification of head pain. , 1990, Archives of neurology.
[7] T. Kneip,et al. Methods for biological monitoring : a manual for assessing human exposure to hazardous substances , 1988 .
[8] J. Noth,et al. An increased frequency of patent foramen ovale in patients with transient global amnesia. Analysis of 53 consecutive patients. , 1996, Archives of neurology.
[9] N. Lassen,et al. Ischemia may be the primary cause of the neurologic deficits in classic migraine. , 1987, Archives of neurology.
[10] A. Sadovnick. Familial recurrence risks and inheritance of multiple sclerosis. , 1993, Current opinion in neurology and neurosurgery.
[11] D. Baker,et al. Genetic analysis of experimental allergic encephalomyelitis in mice. , 1995, Journal of immunology.
[12] D. Miller,et al. The British Isles survey of multiple sclerosis in twins , 1994, Neurology.
[13] S. Poser,et al. Prognosis of multiple sclerosis. Results from an epidemiological area in Germany. , 1982, Acta neurologica Scandinavica.
[14] R. Sacco,et al. Patent Foramen Ovale as a Risk Factor for Cryptogenic Stroke , 1992, Annals of Internal Medicine.
[15] 北野 あゆみ. Increased 11-dehydrothromboxane B[2] in migraine : platelet hyperfunction in patients with migraine during headachefree period , 1995 .
[16] D. Hinds,et al. A full genome search in multiple sclerosis , 1996, Nature Genetics.
[17] C. Thomsen,et al. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. , 1992, Magnetic resonance imaging.
[18] P. Portegies,et al. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. , 1989, BMJ.
[19] N. Risch,et al. Evidence for genetic basis of multiple sclerosis , 1996, The Lancet.
[20] J. Durnin,et al. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years , 1974, British Journal of Nutrition.
[21] B S Schwartz,et al. Predictors of dimercaptosuccinic acid chelatable lead and tibial lead in former organolead manufacturing workers. , 1999, Occupational and environmental medicine.
[22] P. Goodfellow,et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 , 1996, Nature Genetics.
[23] J. Feldman,et al. National health and nutrition examination I--epidemiologic follow-up survey. , 1983, Public health reports.
[24] J. Sidtis,et al. Neuropsychological characterization of the AIDS dementia complex: a preliminary report. , 1988, AIDS.
[25] M. Zuber,et al. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. , 1995, American heart journal.
[26] W. Edwards,et al. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. , 1984, Mayo Clinic proceedings.
[27] G. Anzola,et al. Validation of Transcranial Doppler Sonography in the Assessment of Patent Foramen Ovale , 1995 .
[28] H. Mitsuya,et al. Effect of combination therapy with zidovudine and didanosine on neuropsychological functioning in patients with symptomatic HIV disease: a comparison of simultaneous and alternating regimens , 1997, AIDS.
[29] J. Becker,et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. , 1994, Neurology.
[30] B. Rabin,et al. Immunologic response to acute psychological stress in MS patients and controls , 1996, Journal of Neuroimmunology.
[31] D R Hoover,et al. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. , 1996, Journal of neurovirology.
[32] R. Janssen,et al. Intracerebral hemorrhage in blacks. Risk factors, subtypes, and outcome. , 1997, Stroke.
[33] S. Zeger,et al. Longitudinal data analysis using generalized linear models , 1986 .
[34] I. Lundberg,et al. Neuropsychological verbal tests may lack "hold" properties in occupational studies of neurotoxic effects. , 1996, Occupational and environmental medicine.
[35] L. C. Montgomery. The Medical Clinics of North America , 1928 .
[36] T. Olsson,et al. Genetic analysis of inflammation, cytokine mRNA expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats , 1997, Journal of Neuroimmunology.
[37] C. Kase,et al. Stroke in South Alabama: Incidence and Diagnostic Features - A Population Based Study , 1984, Stroke.
[38] A. Saykin,et al. Neuropsychological dysfunction in HIV-infection: Characterization in a lymphadenopathy cohort , 1988 .
[39] M. Daly,et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. , 1997, American journal of human genetics.
[40] A Capdevila,et al. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis , 1997, Neurology.
[41] M. Hamilton,et al. Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.
[42] M. Kremenchutzky. [The natural history of multiple sclerosis]. , 2000, Revista de neurologia.
[43] O. Spreen,et al. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary , 1991 .
[44] B. Dahlbäck. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. , 1995, Blood.
[45] Y. Fragoso. Reduction of Migraine Attacks During the Use of Warfarin , 1997, Headache.
[46] A. Rotnitzky,et al. K X-ray fluorescence measurements of bone lead concentration: the analysis of low-level data , 1995, Physics in medicine and biology.
[47] J. Noth,et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. , 1997, The American journal of cardiology.
[48] W. Cleveland. Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .
[49] J V Hajnal,et al. Normal and abnormal white matter tracts shown by MR imaging using directional diffusion weighted sequences. , 1990, Journal of computer assisted tomography.
[50] M. Bleecker,et al. Differential contribution of current and cumulative indices of lead dose to neuropsychological performance by age , 1997, Neurology.
[51] C. Spielberger,et al. Manual for the State-Trait Anxiety Inventory , 1970 .
[52] P. Basser,et al. Estimation of the effective self-diffusion tensor from the NMR spin echo. , 1994, Journal of magnetic resonance. Series B.
[53] R. Sacco,et al. Vascular distribution of paradoxical emboli by transcranial Doppler , 1993, Neurology.
[54] P. Goodfellow,et al. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. , 1998, Brain : a journal of neurology.
[55] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[56] C. Thomsen,et al. Increased water self‐diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis , 1993, Acta neurologica Scandinavica.
[57] D. Clayton,et al. Clinical concordance in sibling pairs with multiple sclerosis , 1996, Neurology.
[58] A. S. Hall,et al. NUCLEAR MAGNETIC RESONANCE IMAGING OF THE BRAIN IN MULTIPLE SCLEROSIS , 1981, The Lancet.
[59] R. Rudick,et al. Multiple sclerosis : advances in clinical trial design, treatment, and future perspectives , 1996 .
[60] A. Spiro,et al. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. , 1998, Neurotoxicology and teratology.
[61] T. Brott,et al. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. , 1986, Stroke.
[62] M. Clanet,et al. A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS , 1998, Neurology.
[63] J. Taubenberger,et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.
[64] C. Decarli,et al. Brain growth and cognitive improvement in children with human immunodeficiency virus-induced encephalopathy after 6 months of continuous infusion zidovudine therapy. , 1991, Journal of acquired immune deficiency syndromes.
[65] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[66] W. Grove. Statistical Methods for Rates and Proportions, 2nd ed , 1981 .
[67] A. Thompson,et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.
[68] A. Todd,et al. In vivo X-ray fluorescence of lead in bone using K X-ray excitation with 109Cd sources: radiation dosimetry studies. , 1992, Environmental research.
[69] D. Goodkin. Clinical demographics of multiplex families with multiple sclerosis , 1998, Annals of neurology.
[70] P. Guéret,et al. Contrast echocardiographic visualization of cough-induced right to left shunt through a patent foramen ovale. , 1984, Journal of the American College of Cardiology.
[71] J. Broderick,et al. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. , 1992, The New England journal of medicine.
[72] Denis Le Bihan,et al. Imagerie de diffusion in-vivo par résonance magnétique nucléaire , 1985 .
[73] J. Whisnant,et al. Patent foramen ovale in patients with cerebral infarction. A transesophageal echocardiographic study. , 1997, Archives of neurology.
[74] R. Janssen,et al. Stroke in young black patients. Risk factors, subtypes, and prognosis. , 1995, Stroke.
[75] Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. , 1987, MMWR supplements.
[76] X. Montalban,et al. Amelioration of flulike symptoms at the onset of interferon β‐ 1b therapy in multiple sclerosis by low‐dose oral steroids is related to a decrease in interleukin‐6 induction , 1998, Annals of neurology.
[77] Hans Lassmann,et al. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.
[78] J. Oger,et al. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes , 1982, Journal of the Neurological Sciences.
[79] F. Barkhof,et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.
[80] J. Rockstroh,et al. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV‐infected patients , 1997, AIDS.
[81] W. Stewart,et al. Comparison of neurobehavioral function in workers exposed to a mixture of organic and inorganic lead and in workers exposed to solvents. , 1995, American journal of industrial medicine.
[82] N. Risch,et al. A genetic basis for familial aggregation in multiple sclerosis , 1995, Nature.
[83] R. Sacco,et al. Characteristics of Patent Foramen Ovale Associated With Cryptogenic Stroke: A Biplane Transesophageal Echocardiographic Study , 1994, Stroke.
[84] H. Brodt,et al. Changing incidence of AIDS‐defining illnesses in the era of antiretroviral combination therapy , 1997, AIDS.
[85] G. Barker,et al. Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.
[86] Howard Hu,et al. X-ray fluorescence: issues surrounding the application of a new tool for measuring burden of lead. , 1989, Environmental research.
[87] X. Montalban,et al. Low‐dose steroids reduce flu‐like symptoms at the initiation of IFNP‐1b in relapsing‐remitting MS , 1998, Neurology.
[88] J. Phair,et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.
[89] O. Selnes,et al. Normative Data for a Brief Neuropsychological Screening Battery , 1991, Perceptual and motor skills.
[90] J. Manson,et al. Migraine and subsequent risk of stroke in the Physicians' Health Study. , 1995, Archives of neurology.
[91] F. Goebel,et al. Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[92] J Agnew,et al. Decrements in neurobehavioral performance associated with mixed exposure to organic and inorganic lead. , 1993, American journal of epidemiology.
[93] R. Joffe,et al. Mood disorder and multiple sclerosis. , 1987, Archives of neurology.
[94] H. J. Smith,et al. PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS , 1988, The Lancet.
[95] Andrew J. Saykin,et al. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection , 1991, Neurology.
[96] S. Hernberg,et al. Psychological performance of subjects with low exposure to lead. , 1978, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[97] G. Barker,et al. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.
[98] D. Mohr,et al. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. , 1997, Archives of neurology.
[99] M. Hirsch,et al. Zidovudine treatment of the AIDS dementia complex: Results of a placebo‐controlled trial , 1993, Annals of neurology.
[100] D. Kleinbaum,et al. Applied Regression Analysis and Other Multivariate Methods , 1978 .
[101] S. Kittner,et al. Black‐White Differences in Stroke Risk Among Young Adults , 1993, Stroke.
[102] R. Sacco,et al. Hospitalized Stroke in Blacks and Hispanics in Northern Manhattan , 1991, Stroke.
[103] J. Phair,et al. Survival in HIV-Infected Patients Who Have Received Zidovudine: Comparison of Combination Therapy with Sequential Monotherapy and Continued Zidovudine Monotherapy , 1996, Annals of Internal Medicine.
[104] E L Baker,et al. Occupational lead neurotoxicity: improvement in behavioural effects after reduction of exposure. , 1985, British journal of industrial medicine.
[105] A. Sadovnick,et al. Age of onset in siblings concordant for multiple sclerosis. , 1991, Brain : a journal of neurology.
[106] R Attewell,et al. In vivo measurements of lead in bone in long-term exposed lead smelter workers. , 1993, Archives of environmental health.
[107] P. Basser,et al. Diffusion tensor MR imaging of the human brain. , 1996, Radiology.
[108] W. Stewart,et al. delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid. , 1997, Occupational and environmental medicine.
[109] C. Poser,et al. The epidemiology of multiple sclerosis: A general overview , 1994, Annals of neurology.
[110] P. Basser,et al. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.
[111] D. Rubinow,et al. Neuropsychiatric consequences of AIDS , 1988, Annals of neurology.
[112] F. Schmitt,et al. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. , 1988, The New England journal of medicine.
[113] David H. Miller,et al. Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance , 1996, Magnetic resonance in medicine.
[114] M. Kolczak,et al. Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. , 1998, Occupational and environmental medicine.
[115] E. Miller,et al. Neuropsychological performance in HIV-1 immunocompromised patients: a preliminary report. , 1989, Journal of clinical and experimental neuropsychology.
[116] F. Chédru,et al. Atrial Septal Aneurysm and Patent Foramen Ovale as Risk Factors for Cryptogenic Stroke in Patients Less Than 55 Years of Age: A Study Using Transesophageal Echocardiography , 1993, Stroke.
[117] D. Paty,et al. A population‐based study of multiple sclerosis in twins: Update , 1993 .
[118] S. Skerfving,et al. A neurobehavioural study of long-term occupational inorganic lead exposure. , 1997, The Science of the total environment.
[119] B. Everitt,et al. Statistical methods for rates and proportions , 1973 .
[120] D. Schaid,et al. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis , 1997, Neurology.
[121] R. Reitan. Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .
[122] W. Stewart,et al. Cumulative exposure to inorganic lead and neurobehavioural test performance in adults: an epidemiological review. , 1995, Occupational and environmental medicine.
[123] G. Aimard,et al. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. , 1980, Brain : a journal of neurology.
[124] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[125] N. Risch,et al. Effect of age at onset and parental disease status on sibling risks for MS , 1998, Neurology.
[126] J. Baskerville,et al. A comparison of sporadic and familial multiple sclerosis , 1990, Neurology.
[127] W. Stewart,et al. Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites. , 1995, Occupational and environmental medicine.
[128] P. Basser,et al. Toward a quantitative assessment of diffusion anisotropy , 1996, Magnetic resonance in medicine.
[129] J. Becker,et al. Neuropsychological performance in HIV‐1‐infected homosexual men , 1990, Neurology.
[130] E. Bromet,et al. Low level lead exposure and neuropsychological functioning in blue collar males. , 1987, The International journal of neuroscience.
[131] M. Clanet,et al. Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS. , 1997 .
[132] I. Allen,et al. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.
[133] M. Bleecker,et al. Relation of cumulative exposure to inorganic lead and neuropsychological test performance. , 1996, Occupational and environmental medicine.
[134] F. McNeill,et al. In vivo measurements of lead in bone using a 109Cd 'spot' source. , 1993, Basic life sciences.
[135] C. Beaulieu,et al. Determinants of anisotropic water diffusion in nerves , 1994, Magnetic resonance in medicine.
[136] J. Phair,et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. , 1987, The New England journal of medicine.